跳至主要内容
临床试验/NCT00564031
NCT00564031已完成3 期

Hormonal Replacement Therapy and Small Artery Function

Karolinska University Hospital1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2003年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
66
试验地点
1
主要终点
endothelium-dependent dilatation

研究概览

简要总结

Endothelial dysfunction in resistance arteries in women after the menopause is important for the development of high blood pressure and cardiovascular disease

详细描述

We aim to study the effects of different hormone replacement therapies (HRT) on the function and morphology of resistance arteries, and to look for their mechanistic basis. We expect that HRT with estrogens or in combination with MPA may benefit the function of resistance arteries and may preserve the morphological integrity of endothelial cells by regulatory actions on the cytoskeleton.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
50 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • All women had been amenorrheic for at least 1.5 year.
  • Menopausal status was confirmed by a serum concentration of follicular- stimulating hormone (FSH > 34 IU/ml) and estradiol (E2 <50 pmol/l).

排除标准

  • Cigarette smokers and women with:
  • Hypertension
  • Diabetes mellitus
  • Clinical manifestations of arteriosclerosis (coronary heart disease, peripheral artery disease, or cerebrovascular disease)
  • Venous thromboembolic disease
  • Liver disorders
  • Unexplained vaginal bleeding; and
  • Personal or family history of breast cancer were excluded.

研究组 & 干预措施

1

Placebo Comparator

干预措施: placebo (Drug)

2

Experimental

干预措施: Femanest (Drug)

3

Experimental

干预措施: gestapuran (Drug)

4

Experimental

干预措施: Femanest plus Gestapuran (Drug)

结局指标

主要结局

endothelium-dependent dilatation

时间窗: 3 month

次要结局

  • pressure-induced tone and vascular morphology(3 month)

研究者

发起方
Karolinska University Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验